Intestinal Microbiota in Stem Cell Transplant Transplant Admission
ConditionStem Cell Transplant Complications
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorHenry Ford Health System
About this trial
In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.
Eligibility criteria
Qualifiers
Patients aged 18-80 years
patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure
Disqualifiers
None
Trial design
Treatments tested in this trial
- intestinal microbiota
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov